Although the CMA decision regarding liothyronine still appears to be under appeal, the CMA has now fined two more companies - for the same practice but for phenytoin.
Over £70m in fines for pharma giants in price surge probe
• 22 Jul 2022
• News
The Competition and Markets Authority (CMA) has fined pharmaceutical companies Pfizer and Flynn £63 million and £6.7m respectively after it decided they unfairly hiked the price of phenytoin sodium capsules.
You will have only limited, if any, access unless signed up.
ADVANZ FINED! Fines of over £100m dished out for unfair pricing of liothyronine 
T3 liothyronine - for anyone already prescribed or trying to be prescribed - drug firm fined at last
Mercury Pharma Liothyronine
